Alzheimer’s drug approved despite not one FDA adviser recommending it
Click here to watch the investigation on Alzheimer’s drug that aired prior to its approval The FDA has just approved a new treatment for early Alzheimer’s that’s being billed as the first potential “cure” that addresses the root cause rather than just treats symptoms. The drug, aducanumab, could provide hope to millions of patients and […]
Continue reading Alzheimer’s drug approved despite not one FDA adviser recommending it on sharylattkisson.com.
